Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Interrupted Vaginal Probiotic for Bacterial Vaginosis
NCT03234517Phase 2Unknown
- Sponsor
- Zagazig University
- Start
- Aug 2016
- Primary completion
- Aug 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in bacterial vaginosis (BV), sponsored by Zagazig University. Status: unknown.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03234517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234517.